Exact Mass: 268.0978

Exact Mass Matches: 268.0978

Found 218 metabolites which its exact mass value is equals to given mass value 268.0978, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-Hydroxybenzo(a)pyrene

pentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(18),2,4,6,8,10,12,14,16,19-decaen-13-ol

C20H12O (268.0888)

CONFIDENCE standard compound; INTERNAL_ID 45

8-Azaadenosine

C9H12N6O4 (268.092)

Pifithrin-Beta

2-p-Tolyl-5,6,7,8-tetrahydrobenzo[d]imidazo[2,1-b]thiazole

C16H16N2S (268.1034)

2-Hydroxybenzo(a)pyrene

C20H12O (268.0888)

9-Hydroxybenzo[a]pyrene

pentacyclo[10.6.2.0^{2,7}.0^{9,19}.0^{16,20}]icosa-1,3,5,7,9(19),10,12(20),13,15,17-decaen-4-ol

C20H12O (268.0888)

9-Hydroxybenzo[a]pyrene, also known as benzo[Def]chrysen-9-ol or 9-hydroxybenzo(a)Pyrene, 3H-labeled, is classified as a member of the Benzopyrenes. Benzopyrenes are organic compounds containing a benzene fused to a pyrene(benzo[def]phenanthrene) ring system. 9-Hydroxybenzo[a]pyrene is considered to be practically insoluble (in water) and acidic

Benzo[a]pyrene-9,10-oxide

4-oxahexacyclo[11.6.2.0²,⁸.0³,⁵.0¹⁰,²⁰.0¹⁷,²¹]henicosa-1(20),2(8),6,9,11,13(21),14,16,18-nonaene

C20H12O (268.0888)

This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.

Benzo[a]pyrene-7,8-oxide

6-oxahexacyclo[11.6.2.0²,⁸.0⁵,⁷.0¹⁰,²⁰.0¹⁷,²¹]henicosa-1,3,8,10(20),11,13(21),14,16,18-nonaene

C20H12O (268.0888)

This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.

Benzo[a]pyrene-4,5-oxide

18-oxahexacyclo[10.7.2.0³,⁸.0⁹,²⁰.0¹⁶,²¹.0¹⁷,¹⁹]henicosa-1,3,5,7,9(20),10,12(21),13,15-nonaene

C20H12O (268.0888)

This compound belongs to the family of Chrysenes. These are compounds containing the polyaromatic chrysene moiety, which consists of a benzene ring fused to a phenanthrene ring system to form Benzo[a]phenanthrene. D009676 - Noxae > D002273 - Carcinogens

Benzo[a]pyrene-11,12-epoxide

C20H12O (268.0888)

DISPERSE BLUE 1

1,4,5,8-Tetraamino-9,10-anthracenedione

C14H12N4O2 (268.096)

D004396 - Coloring Agents

Musk ambrette

1-(1,1-Dimethylethyl)-2-methoxy-4-methylbenzene nitrated

C12H16N2O5 (268.1059)

D009676 - Noxae > D009153 - Mutagens

Moclobemide

4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide

C13H17ClN2O2 (268.0978)

Moclobemide is only found in individuals that have used or taken this drug. It is a reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder.The mechanism of action of moclobemide involves the selective, reversible inhibition of MAO-A. This inhibition leads to a decrease in the metabolism and destruction of monoamines in the neurotransmitters. This results in an increase in the monoamines, relieving depressive symptoms. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AG - Monoamine oxidase a inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor

Cysteinyl-Phenylalanine

2-[(2-Amino-1-hydroxy-3-sulphanylpropylidene)amino]-3-phenylpropanoic acid

C12H16N2O3S (268.0882)

Cysteinyl-Phenylalanine is a dipeptide composed of cysteine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Phenylalanylcysteine

(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanoic acid

C12H16N2O3S (268.0882)

Phenylalanylcysteine is a dipeptide composed of phenylalanine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Seryltyrosine

(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanoic acid

C12H16N2O5 (268.1059)

Seryltyrosine is a dipeptide composed of serine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Tyrosyl-Serine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-hydroxypropanoate

C12H16N2O5 (268.1059)

Tyrosyl-Serine is a dipeptide composed of tyrosine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

4-O,6-O-Benzylidene-alpha-D-glucopyranose

2-phenyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxine-6,7,8-triol